Next Science Limited is a medical technology company headquartered in Sydney, Australia, with a research and development centre in Florida, USA. It is listed on the ASX under ASX Code ‘NXS’. Next Science’s primary focus is the development and continued commercialisation of its proprietary XbioTM technology to reduce the impact of biofilm based infections in human health.

Shareholder meetings

2023 Annual General Meeting

Next Science’s 2023 AGM was held on Friday, 26 May 2023 at 10:00am (Sydney time).

Click here to listen to the webcast of 2023 AGMOpens in new window

Notice of MeetingOpens in new window
Virtual Meeting GuideOpens in new window
2022 Annual Report Opens in new window

Investor contacts

Investor queries

Next Science Limited
Level 19, Tower A, The Zenith
821 Pacific Highway, Chatswood
NSW 2067
Ph: +61 2 8607 5124
E: [email protected]

Share Registry queries

Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Ph: 1300 554 474